First direct evidence found that the immune system attacks the brain in Parkinson's disease.
“The researchers also think that T-cells may first identify alpha-synuclein in the nervous system of gut then enter the brain where they begin attacking dopaminergic neurons. These findings raise the possibility for an immunotherapy-based treatment.”